Zejia Frank Chen, Liying Zhang, André M Carrington, Rebecca Thornhill, Olivier Miguel, Angela M Auriat, Nima Omid-Fard, Shivaprakash Hiremath, Vered Tshemeister Abitbul, Dar Dowlatshahi, Andrew Demchuk, David Gladstone, Andrea Morotti, Ilaria Casetta, Enrico Fainardi, Thien Huynh, Marah Elkabouli, Zoé Talbot, Gerd Melkus, Richard I Aviv
PURPOSE: Rapid identification of hematoma expansion (HE) risk at baseline is a priority in intracerebral hemorrhage (ICH) patients and may impact clinical decision making. Predictive scores using clinical features and Non-Contract Computed Tomography (NCCT)-based features exist, however, the extent to which each feature set contributes to identification is limited. This paper aims to investigate the relative value of clinical, radiological, and radiomics features in HE prediction. METHODS: Original data was retrospectively obtained from three major prospective clinical trials ["Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (SPOTLIGHT)NCT01359202; The Spot Sign for Predicting and Treating ICH Growth Study (STOP-IT)NCT00810888] Patients baseline and follow-up scans following ICH were included...
April 18, 2023: Canadian Association of Radiologists Journal